Artiva Biotherapeutics, Inc. (ARTV) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Artiva Biotherapeutics, Inc. (ARTV) closed at USD 6.06 on 2026-10-15, a change of +38 % over the past year, with a market capitalization of USD 286.01M.

Artiva Biotherapeutics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Artiva Biotherapeutics, Inc. key figures

Previous close

USD 6.06 (2026-10-15)

1-year change

+38 %

Market cap

USD 286.01M

Enterprise value

USD -53.54M

P/E ratio (trailing)

-1.81

P/E ratio (forward)

-2.24

EPS (trailing)

-3.23

EPS (forward)

-2.61

PEG ratio

n/a

Price to book

0.82

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.88

Employees

115

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Artiva Biotherapeutics, Inc. and compare it with other stocks.